挖掘内在能力概念:它可以应用于阿尔茨海默病吗?
Susana López-Ortiz1, Giuseppe Caruso2, Enzo Emanuele3
1i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), 47012 Valladolid, Spain.
Progress in neurobiology
|January 24, 2024
概括
世界卫生组织 世界卫生组织
科学领域:
- 老年学和神经退行性疾病
- 系统生物学和精准医学 系统生物学和精准医学
背景情况:
- 传统上,老龄化研究专注于疾病,忽视了健康老龄化促进.
- 世界卫生组织 (WHO) 通过内在能力 (IC) 促进健康老龄化,这是一种涵盖运动,活力,感觉,认知和心理领域的指标.
- 阿尔茨海默病 (AD) 研究一直受到单一结果措施的限制,未能捕捉到疾病的复杂性.
研究的目的:
- 探索世卫组织的内在能力 (IC) 概念对阿尔茨海默病 (AD) 患者的适用性.
- 通过IC框架提出一个全面的模型来提高AD诊断和预后.
- 通过个性化医学的系统生物学方法来研究IC的生物学基础.
主要方法:
- 关于健康衰老,内在能力和阿尔茨海默病的现有文献的综述.
- 概念框架开发,将IC领域与AD病理生理学整合起来.
- 关于系统生物学方法的建议,包括OMIC技术,用于在AD中研究IC.
主要成果:
- 内在能力 (IC) 的下降与神经认知障碍有关,包括阿尔茨海默病 (AD).
- 认知,一个核心的IC领域,在AD显著受到影响,涉及多个因素和途径.
- IC概念提供了一种适用于AD的整体框架,有可能改善诊断和预后能力.
结论:
- 内在能力 (IC) 概念可以扩展到阿尔茨海默病 (AD) 患者,提供一种新的评估模型.
- 整合OMIC数据的系统生物学方法对于理解AD中IC的生物基础至关重要.
- 该框架支持精准医学,为阿尔茨海默病患者提供个性化治疗策略.
更多相关视频
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
40.3K
相关概念视频
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Cognitive Development During Adulthood
111
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
111
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
